SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $772,902 | -35.4% | 33,430 | -26.7% | 0.00% | 0.0% |
| Q2 2023 | $1,196,104 | +44.1% | 45,618 | +41.5% | 0.00% | 0.0% |
| Q1 2023 | $829,831 | +35.6% | 32,239 | +37.0% | 0.00% | 0.0% |
| Q4 2022 | $612,171 | -17.4% | 23,536 | -9.2% | 0.00% | 0.0% |
| Q3 2022 | $741,000 | +54.4% | 25,928 | +32.9% | 0.00% | – |
| Q2 2022 | $480,000 | -55.1% | 19,510 | +3.0% | 0.00% | -100.0% |
| Q1 2022 | $1,068,000 | -0.7% | 18,944 | +9.2% | 0.00% | 0.0% |
| Q4 2021 | $1,076,000 | +14.6% | 17,347 | +17.1% | 0.00% | 0.0% |
| Q3 2021 | $939,000 | -8.4% | 14,809 | +19.0% | 0.00% | 0.0% |
| Q2 2021 | $1,025,000 | +3.2% | 12,442 | -7.8% | 0.00% | 0.0% |
| Q1 2021 | $993,000 | -61.7% | 13,489 | -62.3% | 0.00% | 0.0% |
| Q4 2020 | $2,593,000 | +116.8% | 35,753 | +42.6% | 0.00% | 0.0% |
| Q3 2020 | $1,196,000 | +179.4% | 25,072 | +146.0% | 0.00% | – |
| Q2 2020 | $428,000 | -27.7% | 10,193 | -62.7% | 0.00% | – |
| Q3 2019 | $592,000 | – | 27,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |